ANP.AX Gross Margin

The Gross Margin of Antisense Therapeutics Ltd (ANP.AX) is 97.91%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

ANP.AX Gross Margin - Historical Value

Date	Value
2023-06-30	97.91%
2022-06-30	96.29%
2021-06-30	80.97%

ANP.AX Gross Margin - Peers Comparison

Ticker	Name	Value
RNO.AX	Rhinomed Ltd	74.82%
ZLD.AX	Zelira Therapeutics Ltd	11.12%
CAN.AX	Cann Group Ltd	30.50%
IDT.AX	IDT Australia Ltd	80.11%
IHL.AX	Incannex Healthcare Ltd	48.23%
PXS.AX	Pharmaxis Ltd	85.23%
BOT.AX	Botanix Pharmaceuticals Ltd	-51.99%
IVX.AX	Invion Ltd	29.51%
WFL.AX	Wellfully Ltd	53.07%
RCE.AX	Recce Pharmaceuticals Ltd	-207.65%
4586.T	Medrx Co Ltd	99.88%
AC8.AX	Auscann Group Holdings Ltd	100.00%
AGH.AX	Althea Group Holdings Ltd	60.70%
AVE.AX	Avecho Biotechnology Ltd	59.32%
CGB.AX	Cann Global Ltd	-13.90%
ECS.AX	ECS Botanics Holdings Ltd	36.32%
ACR.AX	Acrux Ltd	51.14%
SPL.AX	Starpharma Holdings Ltd	93.52%
204840.KQ	GL Pharm Tech Corp	39.57%
IXC.AX	Invex Therapeutics Ltd	7775.20%
NYR.AX	Nyrada Inc	-348.25%
PAA.AX	Neurizon Therapeutics Ltd	79.81%
LGP.AX	Little Green Pharma Ltd	53.18%
MXC.AX	MGC Pharmaceuticals Ltd	37.98%
NEU.AX	Neuren Pharmaceuticals Ltd	18.56%